Observational Study
Copyright ©The Author(s) 2022.
World J Transplant. May 18, 2022; 12(5): 100-111
Published online May 18, 2022. doi: 10.5500/wjt.v12.i5.100
Table 1 Donor and recipient characteristics of 154 kidney transplant recipients suffering from autosomal dominant polycystic kidney with or without associated ipsilateral nephrectomy during isolated kidney transplantation in a single center transplant program from January 2007 until January 2019

KT alone group (n = 77)
KT with associated ipsilateral nephrectomy (n = 77)
P value
Donor characteristics
Age, yr46.23 ± 14.9447.40 ± 14.86NS
Gender, male/female, n (%)42/35 (54.5/45.5)37/40 (48.1/51.9)NS
CMV status, negative/positive, n (%)32/43 (55.2/47.8)26/47 (35.6/64.4)NS
Type of donor, living/deceased donor, n (%)6/71 (7.8/92.2)21/56 (27.3/72.7)a
Type of deceased donor, DBD/DCD, n (%)54/17 (76.1/23.9)38/18 (67.9/32.1)NS
Recipient characteristics
Age, yr57.40 ± 9.8953.40 ± 9.12NS
Gender, male/female, n (%)48/29 (62.3/37.7)47/30 (61.0/38.9)NS
Body mass index, kg/m²25.69 ± 4.0025.33 ± 3.76NS
Blood group, n (%)NS
A33 (42.9)42 (54.5)NS
B5 (6.5)4 (5.2)NS
AB0 (0)3 (3.9)NS
O39 (50.6)28 (36.4)NS
Pretransplant dialysis versus preemptive kidney transplant, n (%)65/12 (84.4/15.6)55/22 (71.4/28.6)NS
Residual urine diuresis before transplant, mL1057.75 ± 852.841188.42 ± 818.65NS
Rank of transplantNS
First transplant, n (%)73 (94.8)76 (98.7)NS
Second transplant, n (%)3 (3.9)1 (1.3)NS
Third transplant, n (%)1 (1.3)0 (0)NS
Time on dialysis before transplantation, d1105 ± 1198720 ± 757NS
HLA Mismatching (MM), n (%)NS
0 MM 11 (14.3)6 (7.8)
1 MM8 (10.4)7 (9.1)
2 MM30 (39.0)16 (30.8)
3 MM23 (29.9)30 (39)
4 MM2 (2.6)7 (9.1)
5 MM3 (3.9)6 (7.8)
6 MM0 (0.0)5 (6.5)
Hemoglobin before transplantation, g/dL12.47 ± 1.7212.69 ± 1.18NS
Albumin before transplantation, g/dL4.32 ± 0.404.24 ± 0.41NS
Peritransplant plasmapheresis treatment, n (%)14 (18)3 (4)a